Disc Medicine, Inc. is a clinical-stage biopharmaceutical company dedicated to advancing the frontiers of biology to create life-changing medicines in the field of hematology. The company is committed to developing new therapies for a range of hematologic diseases, from rare genetic disorders to blood cancers and complications of chronic diseases.

Disc Medicine

Disc Medicine, Inc.

Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.

Disc Medicine is a biopharmaceutical company dedicated to transforming the lives of patients with hematologic disorders. We are building a unique portfolio of innovative, first-in-class therapeutic candidates that affect fundamental pathways of red blood cell biology.

COM:DISCMEDICINE

Disc Medicine, Inc.

Last Close

63.51

22/11 21:00

Market Cap

1.36B

Beta: -

Volume Today

276.55K

Avg: -

name

homepage url

country

linkedin url

crunchbase url

employee count

sector

industry

Description

peer of

Metrics